Image from Google Jackets

Head and neck cancer : epidemiology, management and treatment outcomes [E-Book]

Contributor(s): Series: Cancer etiology, diagnosis, and treatmentsPublisher: New York : Nova Biomedical, [2015]Description: 1 online resourceContent type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9781634821148
  • 1634821149
Subject(s): Online resources:
Contents:
Chapter 1: Management of Mucositis in Head and Neck Cancer Patients; Abstract; Introduction; Clinical Course and Impact of OM; Assessment of Mucositis; Mucositis Prevention; Mucositis-Associated Pain; Opioid Use for Management of Mucositis-Associated Pain; Adjuvant Analgesic Therapies; Nutrition, Hydration and Electrolyte Support during Treatment; Conclusion and Future Directions
2.2. Downstream Signaling Pathways of HER22.3. Gene Amplification, Protein Overexpression and Mutation of HER2; 3. The Significance of HER2 in; Head and Neck Cancer Treatment; 4. Specific Drugs Targeting HER2; 4.1. Monoclonal Antibodies; 4.2. Tyrosine Kinase Inhibitors; 4.2.1. Lapatinib; 4.2.2. Afatinib; 4.2.3. Dacomitinib; 5. Clinical Trials on HER2 in Head and Neck Cancer; Conclusion; References; Chapter 4: Current Trends and Management in Head and Neck Cancers; Abstract; 1. Head and Neck Squamous Cell Carcinoma; 3. Pathogenesis of Head and Neck Cancers; (i) p53 Pathway
Summary: Over 50,000 new cases of head and neck cancer are diagnosed each year in the United States. The majority of these are squamous cell carcinoma (HNSCC), associated with human papillomavirus infection and carcinogenic behaviors such as tobacco use and alcohol consumption. Although these are more common, there are several other causes that this book addresses. This book examines the epidemiology of head and neck cancer. It discusses the management of head neck cancer as well as treatment outcomes.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Home library Class number URL Status Date due Barcode
Electronic book Stenhouse Library Link to resource Available

Includes bibliographical references and index.

Description based on print version record and CIP data provided by publisher.

Chapter 1: Management of Mucositis in Head and Neck Cancer Patients; Abstract; Introduction; Clinical Course and Impact of OM; Assessment of Mucositis; Mucositis Prevention; Mucositis-Associated Pain; Opioid Use for Management of Mucositis-Associated Pain; Adjuvant Analgesic Therapies; Nutrition, Hydration and Electrolyte Support during Treatment; Conclusion and Future Directions

2.2. Downstream Signaling Pathways of HER22.3. Gene Amplification, Protein Overexpression and Mutation of HER2; 3. The Significance of HER2 in; Head and Neck Cancer Treatment; 4. Specific Drugs Targeting HER2; 4.1. Monoclonal Antibodies; 4.2. Tyrosine Kinase Inhibitors; 4.2.1. Lapatinib; 4.2.2. Afatinib; 4.2.3. Dacomitinib; 5. Clinical Trials on HER2 in Head and Neck Cancer; Conclusion; References; Chapter 4: Current Trends and Management in Head and Neck Cancers; Abstract; 1. Head and Neck Squamous Cell Carcinoma; 3. Pathogenesis of Head and Neck Cancers; (i) p53 Pathway

Over 50,000 new cases of head and neck cancer are diagnosed each year in the United States. The majority of these are squamous cell carcinoma (HNSCC), associated with human papillomavirus infection and carcinogenic behaviors such as tobacco use and alcohol consumption. Although these are more common, there are several other causes that this book addresses. This book examines the epidemiology of head and neck cancer. It discusses the management of head neck cancer as well as treatment outcomes.

Master record variable field(s) change: 050, 082

There are no comments on this title.

to post a comment.
London Health Libraries Koha Consortium privacy notice